Understanding H5N1 Genotype B3.13: Risks, Adaptability, and Human Health Impact
The emergence of highly pathogenic avian influenza (HPAI) A(H5N1) in unexpected animal populations has shifted the landscape of global health surveillance. In 2024, a specific variant—genotype B3.13—emerged from dairy cattle in the United States, leading to sporadic spillover infections in humans. While the prospect of a mammalian-adapted flu virus often sparks concern, current research provides a nuanced view of the risk and the biological characteristics of this specific genotype.
What is H5N1 Genotype B3.13?
Genotype B3.13 is a variant of the H5N1 clade 2.3.4.4b. It gained significant attention in March 2024 when it was first detected in U.S. Dairy cattle. Researchers have isolated these viruses from raw milk samples on geographically distinct farms in Texas and Ohio.
Unlike typical avian influenza, B3.13 has demonstrated a capacity to infect mammals. While it primarily circulates in cattle, it has caused approximately 70 zoonotic human infections. For most people, these infections have been mild, typically presenting with symptoms such as coughing and conjunctivitis.
Mammalian Adaptability and Replication
A critical area of study for public health experts is whether the virus is adapting to thrive in human hosts. Current evidence suggests a complex biological profile:
- Tissue Tropism: Studies using human bronchus and lung tissue indicate that B3.13 viruses possess moderate replication competence and can induce robust proinflammatory responses, which suggests a potential risk to human health (CDC/EID).
- Receptor Binding: Despite their ability to replicate in human bronchial epithelial cells, B3.13 viruses still preferentially bind to avian-like receptors (Nature).
- Transmission: In animal models, bovine-derived B3.13 viruses are lethal in mice and ferrets. However, transmission in ferrets occurs through direct contact rather than airborne routes, which significantly lowers the risk of a widespread human pandemic.
Comparing B3.13 and D1.1 Genotypes
Not all H5N1 viruses found in cattle are the same. A second genotype, D1.1, was confirmed in U.S. Cattle on January 31, 2025. The differences between these two are stark:
| Feature | Genotype B3.13 | Genotype D1.1 |
|---|---|---|
| Host Adaptability | Exhibits mammalian adaptability | Retains avian adaptability |
| Human Impact | Typically mild symptoms | Associated with the first fatality in clade 2.3.4.4b |
| Human-like Signatures | Limited occurrences | Limited occurrences |
According to research published in Current Research in Microbial Sciences, while B3.13 shows more mammalian adaptation, both genotypes currently lack the extensive “human-like signatures” that would be required for efficient human-to-human transmission.
Treatment and Prevention
The decent news for clinical management is that B3.13 does not appear to have developed widespread resistance to existing medical countermeasures. Bovine-derived viruses remain susceptible to FDA-approved antivirals. They are inhibited by human sera from clade 2.3.4.4c vaccinees and sera from ferrets vaccinated with WHO-recommended candidate vaccine viruses (CVV) (Nature).
Key Takeaways
- Origin: B3.13 is a clade 2.3.4.4b H5N1 virus found in US dairy cattle.
- Human Risk: The risk to humans who are not in direct contact with affected animals is currently considered low.
- Symptoms: Most human spillover cases from B3.13 have been mild (conjunctivitis and cough).
- Transmission: The virus transmits via direct contact in mammalian models, not airborne.
- Treatment: Existing FDA-approved antivirals remain effective.
Frequently Asked Questions
Can I secure B3.13 from drinking store-bought milk?
While the virus was isolated from raw milk samples, the current scientific consensus emphasizes that the risk to the general public not in contact with affected animals is low. (Always follow local health guidelines regarding pasteurization).
Is B3.13 the same as the “bird flu” we’ve seen in the past?
It is a part of the H5N1 lineage, but it belongs to a specific clade (2.3.4.4b) and genotype (B3.13) that has shown an ability to infect and replicate in cattle, which is a deviation from traditional avian-only patterns.
What is the difference between B3.13 and D1.1?
B3.13 shows higher mammalian adaptability and generally causes mild illness in humans, whereas D1.1 retains more avian characteristics but has been linked to a fatality (ScienceDirect).
Looking Forward: While B3.13 does not currently pose a pandemic threat, the emergence of resistance mutations within clade 2.3.4.4b highlights the require for multi-target antiviral strategies and continued global surveillance to detect any further evolutionary shifts.